Cancer clinical trials in the region Nouvelle-Aquitaine
294 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 2
Lung cancer
#NCT06552234
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
ROS-1
None
1
2
3 or more
Systemic Treatment-Naive
Immunotherapy
Chemotherapy
Targeted therapy
Centre Hospitalier Universitaire Dupuytren (Limoges), Groupe Hospitalier Saint André (Bordeaux)
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Phase 2
Breast cancer
#NCT06330064
#2023-509632-26-00
HER2 Negative
HR Positive
Locally Advanced
Metastatic
2
3 or more
Targeted therapy
Hormone therapy
Systemic Treatment-Naive
Groupe Hospitalier Saint André (Bordeaux), Institut Bergonié (Bordeaux)
Daiichi Sankyo
Phase 2
Breast cancer
#NCT06330064
#2023-509632-26-00
HER2 Low
HR Positive
Locally Advanced
Metastatic
2
3 or more
Targeted therapy
Hormone therapy
Systemic Treatment-Naive
Groupe Hospitalier Saint André (Bordeaux), Institut Bergonié (Bordeaux)
Daiichi Sankyo
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT04116541
#2023-510567-35-00
Locally Advanced
Metastatic
Metastatic Castration-resistant
Other mutation
1
2
3 or more
Systemic Treatment-Naive
Institut Bergonié (Bordeaux)
Centre Léon Bérard
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT04116541
#2023-510567-35-00
Locally Advanced
Metastatic
Metastatic Castration-resistant
BRAF
1
2
3 or more
Systemic Treatment-Naive
Institut Bergonié (Bordeaux)
Centre Léon Bérard
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT04116541
#2023-510567-35-00
Locally Advanced
Metastatic
Metastatic Castration-resistant
ALK
1
2
3 or more
Systemic Treatment-Naive
Institut Bergonié (Bordeaux)
Centre Léon Bérard
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
#NCT04116541
#2023-510567-35-00
Locally Advanced
Metastatic
Metastatic Castration-resistant
EGFR
MET
NTRK-1/2/3
RET
ROS-1
Other mutation
1
2
3 or more
Systemic Treatment-Naive
Institut Bergonié (Bordeaux)
Centre Léon Bérard
Phase 2
Lung cancer
#NCT05061550
#2023-508852-21-00
NSCLC (Non-Small Cell Lung Cancer)
Localized
None
Systemic Treatment-Naive
ALK
EGFR
Centre Hospitalier Universitaire Dupuytren (Limoges)
AstraZeneca
Phase 2
Breast cancer
#NCT06680596
#2024-515349-41-00
HER2 Low
HR Positive
Metastatic
None
Antibody Drug Conjugates (ADC)
Hormone therapy
Polyclinique Pau Pyrénées (Site Marzet) - GBNA Santé (Pau), Centre Hospitalier de la Côte Basque (Bayonne)
UNICANCER
Phase 2
Colon cancer
Rectal cancer
#NCT06792695
#2024-518469-84-00
Adenocarcinoma
Metastatic
MSS/pMMR
None
Systemic Treatment-Naive
Immunotherapy
Immunotherapy
Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers)
AstraZeneca